AMGN vs STEM · P/E 24, rev $36.75B vs rev $144.6M
Amgen Inc (AMGN) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. STEM currently screens at market cap $82.1M.
Not investment advice. Open the AMGN and STEM stock pages for the full models.
Not investment advice.